Hat mitgewirkt an:
-
Modular modification of chimeric antigen receptors sheds light on T cell activation
-
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation
-
Harnessing CD3 diversity to optimize CAR T cells
-
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells